These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 16905688)
1. Elucidating the effect of final-day dosing of rifampin in induction studies on hepatic drug disposition and metabolism. Lam JL; Shugarts SB; Okochi H; Benet LZ J Pharmacol Exp Ther; 2006 Nov; 319(2):864-70. PubMed ID: 16905688 [TBL] [Abstract][Full Text] [Related]
2. Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: studies of digoxin metabolism in primary rat hepatocytes versus microsomes. Lam JL; Benet LZ Drug Metab Dispos; 2004 Nov; 32(11):1311-6. PubMed ID: 15483198 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. Lau YY; Okochi H; Huang Y; Benet LZ Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo correlation of hepatic transporter effects on erythromycin metabolism: characterizing the importance of transporter-enzyme interplay. Lam JL; Okochi H; Huang Y; Benet LZ Drug Metab Dispos; 2006 Aug; 34(8):1336-44. PubMed ID: 16698890 [TBL] [Abstract][Full Text] [Related]
5. Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design. Reitman ML; Chu X; Cai X; Yabut J; Venkatasubramanian R; Zajic S; Stone JA; Ding Y; Witter R; Gibson C; Roupe K; Evers R; Wagner JA; Stoch A Clin Pharmacol Ther; 2011 Feb; 89(2):234-42. PubMed ID: 21191377 [TBL] [Abstract][Full Text] [Related]
6. Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. Lau YY; Okochi H; Huang Y; Benet LZ J Pharmacol Exp Ther; 2006 Feb; 316(2):762-71. PubMed ID: 16258024 [TBL] [Abstract][Full Text] [Related]
7. Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay. Lau YY; Wu CY; Okochi H; Benet LZ J Pharmacol Exp Ther; 2004 Mar; 308(3):1040-5. PubMed ID: 14634033 [TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of saturable hepatic uptake of digoxin and its inhibition by rifampicin. Weiss M; Hung DY; Poenicke K; Roberts MS Eur J Pharm Sci; 2008 Aug; 34(4-5):345-50. PubMed ID: 18573335 [TBL] [Abstract][Full Text] [Related]
9. Vascular binding, blood flow, transporter, and enzyme interactions on the processing of digoxin in rat liver. Liu L; Mak E; Tirona RG; Tan E; Novikoff PM; Wang P; Wolkoff AW; Pang KS J Pharmacol Exp Ther; 2005 Oct; 315(1):433-48. PubMed ID: 15994370 [TBL] [Abstract][Full Text] [Related]
10. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin. Fromm MF; Busse D; Kroemer HK; Eichelbaum M Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178 [TBL] [Abstract][Full Text] [Related]
11. Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers. Burger DM; Agarwala S; Child M; Been-Tiktak A; Wang Y; Bertz R Antimicrob Agents Chemother; 2006 Oct; 50(10):3336-42. PubMed ID: 17005814 [TBL] [Abstract][Full Text] [Related]
12. Effect of macrolide antibiotics on uptake of digoxin into rat liver. Ito S; Nasu R; Tsujimoto M; Murakami H; Ohtani H; Sawada Y Biopharm Drug Dispos; 2007 Apr; 28(3):113-23. PubMed ID: 17253595 [TBL] [Abstract][Full Text] [Related]
13. Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat. Garver E; Hugger ED; Shearn SP; Rao A; Dawson PA; Davis CB; Han C Drug Metab Dispos; 2008 Dec; 36(12):2492-8. PubMed ID: 18755851 [TBL] [Abstract][Full Text] [Related]
14. Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In Vivo. Niu C; Wang Y; Zhao X; Tep S; Murakami E; Subramanian R; Smith B; Lai Y Drug Metab Dispos; 2019 Dec; 47(12):1433-1442. PubMed ID: 31582395 [TBL] [Abstract][Full Text] [Related]
15. Pitavastatin as an in vivo probe for studying hepatic organic anion transporting polypeptide-mediated drug-drug interactions in cynomolgus monkeys. Takahashi T; Ohtsuka T; Yoshikawa T; Tatekawa I; Uno Y; Utoh M; Yamazaki H; Kume T Drug Metab Dispos; 2013 Oct; 41(10):1875-82. PubMed ID: 23929936 [TBL] [Abstract][Full Text] [Related]
16. Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitor. Imaoka T; Mikkaichi T; Abe K; Hirouchi M; Okudaira N; Izumi T Drug Metab Dispos; 2013 Jul; 41(7):1442-9. PubMed ID: 23640987 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the uptake of rocuronium and digoxin in human hepatocytes: carrier specificity and comparison with in vivo data. Olinga P; Merema M; Hof IH; Slooff MJ; Proost JH; Meijer DK; Groothuis GM J Pharmacol Exp Ther; 1998 May; 285(2):506-10. PubMed ID: 9580590 [TBL] [Abstract][Full Text] [Related]
18. Absence of OATP1B (Organic Anion-Transporting Polypeptide) Induction by Rifampin in Cynomolgus Monkeys: Determination Using the Endogenous OATP1B Marker Coproporphyrin and Tissue Gene Expression. Zhang Y; Chen C; Chen SJ; Chen XQ; Shuster DJ; Puszczalo PD; Fancher RM; Yang Z; Sinz M; Shen H J Pharmacol Exp Ther; 2020 Oct; 375(1):139-151. PubMed ID: 32719071 [TBL] [Abstract][Full Text] [Related]
19. Disposition of tacrolimus in isolated perfused rat liver: influence of troleandomycin, cyclosporine, and gg918. Wu CY; Benet LZ Drug Metab Dispos; 2003 Nov; 31(11):1292-5. PubMed ID: 14570757 [TBL] [Abstract][Full Text] [Related]
20. Rifampin induces the in vitro oxidative metabolism, but not the in vivo clearance of diclofenac in rhesus monkeys. Prueksaritanont T; Li C; Tang C; Kuo Y; Strong-Basalyga K; Carr B Drug Metab Dispos; 2006 Nov; 34(11):1806-10. PubMed ID: 16928785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]